MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Adaptive Biotechnologies Corporation DIO Ratio 2011-2026 | ADPT
Annual DIO Ratio Adaptive Biotechnologies Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.7 | 58 | 69.8 | 106 | 123 | 187 | 149 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 187 | 46.7 | 106 |
Quarterly DIO Ratio Adaptive Biotechnologies Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.1 | 43.3 | 46 | - | 68.9 | 62.6 | 70.1 | - | 90.7 | 98.9 | 83.8 | - | 53.1 | 72.5 | 139 | - | 118 | 153 | 144 | - | 212 | 261 | 198 | - | 148 | 144 | 155 | - | 133 | 70.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 261 | 43.3 | 114 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B |  USA |
 |
Aptorum Group Limited
APM
|
4.89 | $ 0.82 | -3.48 % | $ 4.47 M |  China |
 |
Axsome Therapeutics
AXSM
|
168 | $ 164.71 | -1.01 % | $ 8.19 B | USA |
 |
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Catalyst Pharmaceuticals
CPRX
|
119 | $ 23.88 | - | $ 2.92 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - |  Russia |
 |
Eton Pharmaceuticals
ETON
|
25.3 | $ 17.72 | -2.37 % | $ 454 M | USA |
 |
Exelixis
EXEL
|
96.1 | $ 40.99 | -0.1 % | $ 11.1 B | USA |
 |
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | USA |
 |
Galapagos NV
GLPG
|
0.915 | $ 33.13 | -2.82 % | $ 2.69 B |  Belgium |
 |
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M |  Canada |
 |
Codexis
CDXS
|
50.2 | $ 0.99 | -2.92 % | $ 72.7 M | USA |
 |
Halozyme Therapeutics
HALO
|
254 | $ 69.39 | -0.67 % | $ 8.32 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
11.6 | $ 28.56 | -1.19 % | $ 1.64 B | USA |
 |
ImmuCell Corporation
ICCC
|
147 | $ 6.3 | -3.67 % | $ 51.5 M | USA |
 |
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | Canada |
 |
Immuron Limited
IMRN
|
1.32 K | $ 0.75 | -0.69 % | $ 6.43 M |  Australia |
 |
InMed Pharmaceuticals
INM
|
309 | $ 0.75 | -8.49 % | $ 1.84 M | Canada |
 |
Insmed Incorporated
INSM
|
342 | $ 146.89 | 0.39 % | $ 29.2 B | USA |
 |
Agenus
AGEN
|
0.163 | $ 3.19 | -4.49 % | $ 1.14 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
1.74 K | $ 29.11 | -0.31 % | $ 1.69 B | USA |